SCNI
Scinai Immunotherapeutics
SCNI
SCNI
15 hedge funds and large institutions have $2.58M invested in Scinai Immunotherapeutics in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$146K | |
| 2 | +$57K | |
| 3 | +$18K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5K |
Top Sellers
| 1 | -$146K | |
| 2 | -$139K | |
| 3 | -$4.4K | |
| 4 |
EWM
Edge Wealth Management
New York
|
-$1K |
| 5 |
CA
Calton & Associates
Tampa,
Florida
|
-$1K |